---
title: "Standigm agrees partnership with KIST to discover a new drug for Autism"
date: August 10, 2017
image_url: /assets/images/partnership/kist_logo.gif
categories:
  - News
tags:
  - Standigm
  - KIST
  - Artificial intelligence
  - AI-driven drug discovery
  - Autism
---

Standigm and Korea institute of science and technology (KIST) announced a research collaboration to develop a new small molecule medicine for Autism. The drug candidates chosen by Standigm’s AI drug discovery technology will validate experimentally by using KIST’s animal models.
